Bioptik Technology Incorporation (TPEX:4161)
Taiwan
· Delayed Price · Currency is TWD 30.25
-0.60 (-1.94%)
Jun 2, 2025, 1:30 PM CST
TPEX:4161 Revenue
Bioptik Technology Incorporation had revenue of 195.72M TWD in the quarter ending March 31, 2025, a decrease of -10.96%. This brings the company's revenue in the last twelve months to 841.24M, down -5.58% year-over-year. In the year 2024, Bioptik Technology Incorporation had annual revenue of 865.34M with 4.45% growth.
Revenue (ttm)
841.24M
Revenue Growth
-5.58%
P/S Ratio
1.90
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 865.34M | 36.83M | 4.45% |
| Dec 31, 2023 | 828.50M | 60.75M | 7.91% |
| Dec 31, 2022 | 767.75M | 29.86M | 4.05% |
| Dec 31, 2021 | 737.89M | 252.29M | 51.96% |
| Dec 31, 2020 | 485.60M | -80.82M | -14.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Oneness Biotech | 117.33M |
| Lumosa Therapeutics | 43.59M |